【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2200次   下载 1957 本文二维码信息
码上扫一扫!
磺脲类药物对心血管系统影响的基础和临床研究进展
蒋国良,吴国亭*
0
(同济大学附属第十人民医院内分泌科,上海 200072)
摘要:
基础研究表明,磺脲类药物对心血管系统有双向影响:磺脲类药物能够关闭心血管系统ATP敏感性钾通道,从而增高冠脉张力,加重缺血对心血管组织的损伤和促进心脏肥厚的发生;另一方面,磺脲类药物能够激活过氧化物酶体增殖物激活受体,从而调控糖脂代谢,调节炎症反应和抑制动脉粥样硬化的发生。临床流行病学研究显示关于磺脲类药物是否增加心血管疾病死亡率的争论仍存分歧。
关键词:  磺脲类药物  ATP敏感性钾通道  过氧化物酶体增殖物激活受体  心血管疾病
DOI:10.3724/SP.J.1008.2007.01008
基金项目:上海市科委科技攻关重点项目(04DZ19507).
Influence of sulfonylureas on cardiovascular system:progress in basic research and clinical research
JIANG Guo-liang,WU Guo-ting*
(Department of Endocrinology,The Tenth People’s Hospital of Shanghai,Tongji University,Shanghai 200072,China)
Abstract:
Previous studies have showed that sulfonylureas possess a bidirectional effect on cardiovascular system:they can raise the coronary artery tone,aggravate ischemic injury to the cardiovascular tissues,and accelerate cardiac hypertrophy through closing cardiovascular ATP-sensitive K+ channels; meanwhile,they can also regulate glucolipid metabolism,modulate inflammatory reaction and inhibit atherosclerosis through activating peroxisome proliferator-activated receptors.Clinical-epidemiological study showed different opinions on whether sulfonylureas can increase the mortality of patients with cardiovascular diseases.
Key words:  sulfonylureas  ATP-sensitive K+ channels  peroxisome proliferator-activated receptors  cardiovascular disease